ArticleNeuro-oncology advances

Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.

Matthias Holdhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.